Issue № 31 | 2018 (1)
Canada’s health care system is strongly decentralized. Regions independently define the amount of necessary medical care, which causes unequal distribution of medical services and drug supply. The key mechanism of the optimization of public funds and providing appropriate drug care is health technology assessment (HTA) performed independently by the Canadian Agency for Drugs and Technologies in Health (CADTH) using Common Drug Review (CDR) or pan-Canadian Oncology Drug Review (pCODR) procedures. Both reviews include the assessment of clinical and economic effectiveness of drugs and recommendations on reimbursement. Despite the advisory nature of these documents, almost all decisions on the inclusion into the lists of refunded drugs are based on the results of the conducted HTA.
health technology assessment, reimbursement system, Canada’s health care system, drug supply.
Lemeshko V. A., Teptsova T. S. Drug Supply and Health Technology Assessment in Canada’s Health Care System. Medical Technologies. Assessment and Choice. 2018; 1(31): 30–39.